Delivery Order SPE2DB20D1004-SPE2DB25FNGPD
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,490.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a $1,046.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of emtricitabine-tenofovir 100-150mg medication, with a period of performance through April 15, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,689.89, is for the delivery of emtricitabine-tenofovir 200-300 mg medication, with a final completion date of February 27, 2025. The contract is a firm fixed-price delivery order, without any set-aside requirements. AmerisourceBergen holds a larger...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,949.47, is a delivery order for Emtricitabine-Tenofovir 200-300 mg medication in 30-count bottles. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp...
This contract award, valued at $17,495.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 15, 2021. The contract is a delivery order for the supply of 4554791799 units of emtricitabine-tenofovir 200-300mg tablets, a medication used for the treatment of HIV/AIDS. The contract is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,878.79 firm fixed-price contract is to provide emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,054.07 firm fixed-price contract is for the delivery of emtricitabine-tenofovir 200-300 mg medications. It is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $1,241.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, a medication commonly used in the treatment of HIV. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award, valued at $2,704.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emtricitabine-Tenofovir 200-300mg tablets, a medication used in the treatment of HIV/AIDS. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,988.40 order is for the supply of emtricitabine-tenofovir 200-300 milligram tablets, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which...